Blood News and Research

RSS

Pediatricians want kids to be part of COVID vaccine trials

If clinical trials for COVID-19 vaccines aren't expanded soon to include children, it's unlikely that even kids in their teens will be vaccinated in time for the next school year.

15 Dec 2020

Researchers develop new technology for efficient production of monoclonal antibodies

Proteins in biopharmaceutical productions are usually separated and purificated through the expensive chromatography technique. European researchers are developing an innovative membrane crystallization technology to overcome the issue and make the production of monoclonal antibodies more efficient.

15 Dec 2020

Reliable Antibodies Testing for SARS-CoV-2

In this interview, Poncho Meisenheimer, VP of R&D at Promega, talks to News-Medical Life Sciences about the importance of having the reliability for SARS-Co-V-2 antibody tests.

From Promega Corporation 15 Dec 2020

Mologic and the University of Liverpool collaborate to develop a rapid diagnostic test for common agricultural parasite

Mologic today announced it is in the final developmental stages of a pen-diagnostic test with the University of Liverpool.

15 Dec 2020

Study: Structural racism has material impact on health of ethnic minorities, immigrants

Structural racism can lead to discrimination in many aspects of life including criminal justice, employment, housing, health care, political power, and education.

15 Dec 2020

Scientists empower wireless sensors with vision abilities to fight viruses

Current and former early-career scientists share their stories and tell how Europe has bet on them, making their high-risk research possible: from intelligent wireless sensors with vision abilities to RNA-based techniques to fight viruses, from the mathematical formulas of the MRI waves to optoceutics, the new technique that uses light to repair the heart after a stroke.

15 Dec 2020

Smartphone-based adherence program can optimize uptake of COVID-19 vaccine

The light at the end of the pandemic tunnel is getting brighter. This week, the first health care workers will receive the first doses of an FDA-approved coronavirus vaccine. Soon, so will other front-line workers in health care and beyond, and residents of long-term care facilities.

15 Dec 2020

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

Today, the U.S. Food and Drug Administration approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics.

15 Dec 2020

Unique inhibitory protein may suppress the formation of cancer cells

Researchers from Tokyo Medical and Dental University (TMDU) identify a novel role for a protein, vasohibin-1, in preventing cancer cells from spreading

15 Dec 2020

Higher risk of West Nile virus infection in low-income urban neighborhoods in Baltimore

In Baltimore, Maryland, people living in low-income urban neighborhoods are more at risk of contracting West Nile virus, a mosquito-borne disease, than people living in more affluent neighborhoods. So reports a new study published in the Journal of Medical Entomology.

14 Dec 2020

Networks of genes involved in congenital heart disease revealed

Over two million babies, children, and adults in the United States are living with congenital heart disease--a range of birth defects affecting the heart's structure or function.

14 Dec 2020

Huntsman Cancer Institute receives $3 million CDC grant to improve colorectal cancer screening

Huntsman Cancer Institute at the University of Utah has been awarded a five-year, $3 million grant from the Centers for Disease Control and Prevention to improve Utah's colorectal cancer screening rates.

14 Dec 2020

FARI and The Cooper Institute publish new research paper on omega-3s and heart rate recovery

The Fatty Acid Research Institute (FARI) has published a new research paper in conjunction with The Cooper Institute on omega-3s and heart rate recovery.

14 Dec 2020

Landmark heart study reveals new insights about risk factors for depression

Recently published UT Southwestern research reveals new insights about risk factors for depression based on data from a landmark longitudinal study focused on heart disease.

14 Dec 2020

Remdesivir likely to be highly effective treatment for COVID-19

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists.

14 Dec 2020

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Researchers at the Hospices Civils de Lyon (HCL) in France found that people infected with SARS-CoV-2 can develop antibodies that persist for up to six months. After testing commercial assays to detect antibodies, the Wantai antibody assay has a positivity rate of 100%.

14 Dec 2020

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Researchers in the United States and Australia have conducted a comprehensive analysis of the epitope recognition patterns associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans.

14 Dec 2020

Recovered COVID-19 patients exhibit persistent cellular immunity

Researchers at The Rockefeller University in New York have conducted a study showing that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – triggers persistent T cell responses that last for at least six months.

14 Dec 2020

High blood pressure may accelerate cognitive decline at any age

A new study published in Hypertension has found that high blood pressure at any age for any duration may contribute to cognitive decline.

14 Dec 2020

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity

Cancer immunotherapy using "designer" immune cells has revolutionized cancer treatment in recent years. In this type of therapy, T cells, a type of white blood cell, are collected from a patient's blood and subjected to genetic engineering to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) that is designed to enable T cells to recognize and destroy cancer cells.

14 Dec 2020

Blood News and Research

Pediatricians want kids to be part of COVID vaccine trials

Researchers develop new technology for efficient production of monoclonal antibodies

Reliable Antibodies Testing for SARS-CoV-2

Mologic and the University of Liverpool collaborate to develop a rapid diagnostic test for common agricultural parasite

Study: Structural racism has material impact on health of ethnic minorities, immigrants

Scientists empower wireless sensors with vision abilities to fight viruses

Smartphone-based adherence program can optimize uptake of COVID-19 vaccine

FDA approves first IGA in GalSafe pigs for human food, promising therapeutic uses

Unique inhibitory protein may suppress the formation of cancer cells

Higher risk of West Nile virus infection in low-income urban neighborhoods in Baltimore

Networks of genes involved in congenital heart disease revealed

Huntsman Cancer Institute receives $3 million CDC grant to improve colorectal cancer screening

FARI and The Cooper Institute publish new research paper on omega-3s and heart rate recovery

Landmark heart study reveals new insights about risk factors for depression

Remdesivir likely to be highly effective treatment for COVID-19

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Recovered COVID-19 patients exhibit persistent cellular immunity

High blood pressure may accelerate cognitive decline at any age

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News